Cancer is among the leading causes of death worldwide. But now, thanks to a cutting edge COVID vaccine technology, we might be closer to stopping cancer. Germany's BioNTech is launching a UK trial of personalized cancer vaccines this autumn. Subscribe: For more news go to: Follow DW on social media: ►Facebook: ►Twitter: ►Instagram: ►Twitch: Für Videos in deutscher Sprache besuchen Sie: #Cancer #Covid19 #mRNA
Hide player controls
Hide resume playing